Diagnostics News and Research

RSS

Boston Heart receives $1.0M in additional tax incentives through Life Sciences Tax Incentive Program

Boston Heart Diagnostics Corporation, a pioneer in integrating next-generation diagnostics with personal nutrition and lifestyle programs for patients with or at risk for heart disease, has received $1.0 million in additional tax incentives through the Life Sciences Tax Incentive Program.

21 Feb 2014

Convergent announces implementation of PatientQuest patient access solution at Moffitt Cancer Center

Convergent Revenue Cycle Management, Inc., leading provider of healthcare revenue cycle management and patient access solutions to hospitals across the nation, announces today the implementation of their PatientQuest patient access solution at H. Lee Moffitt Cancer Center & Research Institute (Moffitt Cancer Center) in Tampa, Florida. Moffitt Cancer Center is a Siemens Soarian customer.

20 Feb 2014

Professor receives $17M NIH grant to support IMPAACT Network

Grace Aldrovandi, MD, CM, principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, has been awarded $17 million by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

20 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Winnie Palmer Hospital for Women & Babies opens neonatal intensive care unit

Winnie Palmer Hospital for Women & Babies is opening the doors to an expansion of its neonatal intensive care unit (NICU). The expansion, which adds 30 beds to the hospital's existing 112-bed NICU, will make it the largest NICU in the world under one roof.

19 Feb 2014

Ticks infected with the bacterium that causes Lyme disease widespread in San Francisco Bay Area

As winter turns to spring and many Northern Californians plan outdoor adventures, a mysterious, potentially debilitating threat looms.

19 Feb 2014

BioFire Diagnostics submits FilmArray GI Panel to FDA for 510(k) clearance

BioFire Diagnostics, LLC today announced that it has submitted the FilmArray Gastrointestinal (GI) Panel to the U.S. Food and Drug Administration for 510(k) clearance. The comprehensive FilmArray GI Panel tests for over 20 common bacteria, viruses and parasites that cause infectious diarrhea.

18 Feb 2014

Bioline enters Epigenetics field with launch of new EPIK product range

Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc., announces that it has entered the rapidly growing Epigenetics field, with the launch of the first kits in the new EPIK™ product range; EPIK™ Fast Quantification Kit and EPIK™ Amplification Kit.

18 Feb 2014

Upstream interventions may provide options to contain emerging pathogens at source

While many endemic infectious diseases of humans have been largely contained, new microbes continue to emerge to threaten human and animal health.

18 Feb 2014

Advanced Accelerator Applications successfully completes capital increase of €41 million

Advanced Accelerator Applications, a fast growing international specialist in Molecular Nuclear Medicine (MNM), announced today that it had successfully completed a capital increase of €41 million.

17 Feb 2014

Novartis acquires CoStim Pharmaceuticals

MPM Capital and Atlas Venture announced today that portfolio company CoStim Pharmaceuticals, Inc. has been acquired by Novartis for an undisclosed amount. CoStim, founded in 2012 by MPM Managing Director Luke Evnin together with MPM Managing Director-Operations Robert Millman, is an emerging immuno-oncology company developing monoclonal antibody drugs that enable a patient's own immune system to better fight cancer.

17 Feb 2014

Researcher reveals the secrets of Francisella tularensis bacterium that causes tularemia

Tularemia, aka "rabbit fever," is endemic in the northeastern United States, and is considered to be a significant risk to biosecurity -- much like anthrax or smallpox -- because it has already been weaponized in various regions of the world.

17 Feb 2014

Scientists discover novel antibody-based therapy that targets progression of kidney fibrosis

Scientists from the University of Sheffield have developed a novel antibody-based therapy which targets the progression of life threating kidney fibrosis.

16 Feb 2014

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

Prestige Care, Inc., and Prestige Senior Living L.L.C., leaders in exceptional senior living and skilled nursing and rehabilitation care, today announced that they are making plans to join with Carson Tahoe Health to expand quality senior care services and offer comprehensive memory care to Carson City residents and their families. As a first step in the relationship, the organizations will develop a community with 40 units for memory care services on the Carson Tahoe Specialty Medical Center campus. Construction will begin in 2014.

13 Feb 2014

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

Researchers from the Broad Institute and MIT have teamed up with colleagues from the University of Tokyo to form the first high definition picture of the Cas9 complex - a key part of the CRISPR-Cas system used by scientists as a genome-editing tool to silence genes and probe the biology of cells. Their findings, which are reported this week in Cell, are expected to help researchers refine and further engineer the tool to accelerate genomic research and bring the technology closer to use in the treatment of human genetic disease.

13 Feb 2014

GE completes acquisition of API Healthcare

GE announced today it has completed the acquisition of API Healthcare, a healthcare workforce management solutions provider, headquartered in Hartford, WI.

13 Feb 2014

Novogene purchases HiSeq X Ten sequencing system from Illumina

Illumina, Inc. (NASDAQ:ILMN) today announced that Novogene (www.novogene.cn), a leading genomics service provider based in Beijing, China, purchased one HiSeq X Ten.

From Illumina, Inc. 13 Feb 2014

CHOP develops unique laboratory test to characterize genes that encode HLA molecules

Immunogenetics experts at The Children's Hospital of Philadelphia (CHOP) have developed a unique laboratory test to characterize the genes that encode HLA molecules. The test relies on faster, more comprehensive gene sequencing technology to type human leukocyte antigens (HLAs)--complex, highly variable proteins on cell surfaces that are essential to immune function.

13 Feb 2014

LA BioMed researchers test investigational drug for treatment of Sanfilippo B syndrome

A promising new therapy has - for the first time - reduced damage to the brain that can be caused by Sanfilippo B (MPS IIIB), a rare and devastating genetic disease, Los Angeles Biomedical Research Institute researchers will report today in a presentation at the Lysosomal Disease Network's 10th Annual WORLD Symposium-.

12 Feb 2014

ALK announces acquisition of Bio-Medical Services

ALK, the world's leading allergen extract manufacturer, announces the acquisition of Bio-Medical Services, a veterinary reference laboratory who pioneered in vitro serum IgE allergy testing in the veterinary industry.

12 Feb 2014

Diagnostics News and Research

Boston Heart receives $1.0M in additional tax incentives through Life Sciences Tax Incentive Program

Convergent announces implementation of PatientQuest patient access solution at Moffitt Cancer Center

Professor receives $17M NIH grant to support IMPAACT Network

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Winnie Palmer Hospital for Women & Babies opens neonatal intensive care unit

Ticks infected with the bacterium that causes Lyme disease widespread in San Francisco Bay Area

BioFire Diagnostics submits FilmArray GI Panel to FDA for 510(k) clearance

Bioline enters Epigenetics field with launch of new EPIK product range

Upstream interventions may provide options to contain emerging pathogens at source

Advanced Accelerator Applications successfully completes capital increase of €41 million

Novartis acquires CoStim Pharmaceuticals

Researcher reveals the secrets of Francisella tularensis bacterium that causes tularemia

Scientists discover novel antibody-based therapy that targets progression of kidney fibrosis

Prestige Care plans to join with Carson Tahoe Health to expand quality senior care services

Researchers reveal how genome-editing tool works as 'guided missile' to correct errors in genetic code

GE completes acquisition of API Healthcare

Novogene purchases HiSeq X Ten sequencing system from Illumina

CHOP develops unique laboratory test to characterize genes that encode HLA molecules

LA BioMed researchers test investigational drug for treatment of Sanfilippo B syndrome

ALK announces acquisition of Bio-Medical Services

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News